These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3928576

  • 21. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 22. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S, Vickers A, Woodford N, Livermore DM.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1688-1695. PubMed ID: 28333319
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y, Ueda C, Kouyama Y, Tateda K, Yamaguchi K.
    Diagn Microbiol Infect Dis; 2011 Apr 01; 69(4):443-8. PubMed ID: 21396543
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 01; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 25. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Loza E, Morosini MI, Cantón R, Almaraz F, Reig M, Baquero F.
    Rev Esp Quimioter; 2003 Jun 01; 16(2):209-15. PubMed ID: 12973459
    [Abstract] [Full Text] [Related]

  • 26. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Jul 01; 37(7):1547-51. PubMed ID: 8363389
    [Abstract] [Full Text] [Related]

  • 27. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M, Hermida M, Reig R, Esteva C, Vidal R, Roy C.
    Enferm Infecc Microbiol Clin; 1989 Dec 01; 7(10):530-4. PubMed ID: 2518765
    [Abstract] [Full Text] [Related]

  • 28. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
    Alhambra A, Cuadros JA, Cacho J, Gómez-Garcés JL, Alós JI.
    J Antimicrob Chemother; 2004 Jun 01; 53(6):1090-4. PubMed ID: 15117925
    [Abstract] [Full Text] [Related]

  • 29. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J, Calderón C, Sierra MP, Alvarez M, Cantón R.
    Enferm Infecc Microbiol Clin; 1997 Sep 01; 15 Suppl 1():20-6. PubMed ID: 9410065
    [Abstract] [Full Text] [Related]

  • 30. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
    Wise R, Andrews JM, Danks G.
    Antimicrob Agents Chemother; 1983 Dec 01; 24(6):909-14. PubMed ID: 6607032
    [Abstract] [Full Text] [Related]

  • 31. beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.
    Thabaut A, Philippon A, Meyran M.
    Chemioterapia; 1985 Feb 01; 4(1):36-42. PubMed ID: 3921265
    [Abstract] [Full Text] [Related]

  • 32. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ, Traynor EA.
    J Antimicrob Chemother; 1991 Aug 01; 28(2):209-19. PubMed ID: 1778852
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.
    Int J Antimicrob Agents; 2005 Jan 01; 25(1):57-61. PubMed ID: 15620827
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
    Hornstein M, Sautjeau-Rostoker C, Péduzzi J, Vessières A, Hong LT, Barthélémy M, Scavizzi M, Labia R.
    FEMS Microbiol Lett; 1997 Aug 15; 153(2):333-9. PubMed ID: 9271860
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.